Cytosar-u and Rashes - a phase IV clinical study of FDA data

Summary:

Rashes is reported as a side effect among people who take Cytosar-u (cytarabine), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Nexium, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Rashes when taking Cytosar-u. It is created by eHealthMe based on reports of 585 people who have side effects when taking Cytosar-u from the FDA, and is updated regularly.

What is Cytosar-u?

Cytosar-u has active ingredients of cytarabine. eHealthMe is studying from 586 Cytosar-u users. Check the latest studies of Cytosar-u.

What is Rashes?

Rashes (redness) is found to be associated with 3,712 drugs and 6,212 conditions by eHealthMe. Check the latest studies of Rashes.

On Jul, 09, 2026

585 people reported to have side effects when taking Cytosar-u.
Among them, 16 people (2.74%) have Rashes.

Among these 16 people:

How long have people been on Cytosar-u when they have Rashes? *

What is the gender of people who have Rashes when taking Cytosar-u? *

female: 75 %
male: 25 %

What is the age of people who have Rashes when taking Cytosar-u? *

What are other drugs people take besides Cytosar-u? *

Idarubicin Hydrochloride: 11 people, 68.75%
Meropenem: 11 people, 68.75%
Cancidas: 11 people, 68.75%
Escitalopram: 11 people, 68.75%
Famvir: 11 people, 68.75%
Nexium: 11 people, 68.75%
Zolpidem: 10 people, 62.50%
Vfend: 9 people, 56.25%
Flagyl: 9 people, 56.25%
Piperacillin And Tazobactam: 9 people, 56.25%

What are other side effects people have besides Rashes? *

Bleeding Disorders: 11 people, 68.75%
Serotonin Syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time): 11 people, 68.75%
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 11 people, 68.75%
Hepatocellular Injury (liver injury): 11 people, 68.75%
Muscle Aches (muscle pain): 10 people, 62.50%
Cytarabine Syndrome (due to high dose of cytarbine consists of fever, muscle ache, bone pain, occasional chest pain, rash): 9 people, 56.25%
Fever: 3 people, 18.75%
Blood Creatine Phosphokinase Increased: 2 people, 12.50%
Coordination Abnormal (abnormal movement): 2 people, 12.50%
Confusional State: 2 people, 12.50%

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 11 people, 68.75%
Fever: 11 people, 68.75%
Bipolar Disorder (mood disorder): 11 people, 68.75%
Nausea And Vomiting: 9 people, 56.25%
Sleep Disorder: 7 people, 43.75%
Pain: 7 people, 43.75%
Nausea (feeling of having an urge to vomit): 7 people, 43.75%
Depression: 4 people, 25.00%
Leukaemia (blood or bone marrow cancer): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Cytosar-u and have Rashes?

- Check whether Rashes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cytosar-u:

Cytosar-u (586 reports)

Rashes treatments and more:

Rashes (702,909 reports)

Browse all side effects of Cytosar-u:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rashes:

Rashes (3,712 drugs)

Browse all the conditions that are associated with Rashes:

Rashes (6,212 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cytarabine (the active ingredients of Cytosar-u) and Cytosar-u (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.